D75.821
Non-immune heparin-induced thrombocytopenia
Clinical Classification Guidelines
Inclusion Terms
- Non-immune HIT
- Type 1 heparin-induced thrombocytopenia
Medical Intelligence & Overview
Non-immune heparin-induced thrombocytopenia (HIT), classified under ICD-10 code D75.821, is a condition characterized by a low platelet count caused by heparin therapy. Unlike immune-mediated HIT, this form occurs without the formation of antibodies against platelet factor 4 (PF4). It is often considered a less severe, transient condition, typically classified as Type 1 HIT. Recognizing this condition is crucial for healthcare providers to manage anticoagulation therapy effectively and prevent potential complications.
Causes & Symptoms
Clinical Causes: Use of heparin, a common anticoagulant medication, especially during surgeries, dialysis, or treatment of blood clots. Transient platelet activation caused directly by heparin without immune response. Low-grade, non-immune reactions to heparin that lead to temporary platelet activation and reduction. Administration of unfractionated heparin is more commonly associated with HIT, although low molecular weight heparins can also be involved.
Key Symptoms: Mild decrease in platelet counts, often detected during blood tests. No symptoms or very mild symptoms in most cases. Possible minor bruising or bleeding due to low platelet levels, though bleeding is typically less severe than in immune HIT. Occasional symptoms may include skin redness or warmth at injection sites. Rarely, blood clots can form, leading to complications if the condition progresses.
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to monitor platelet levels. Serologic tests for HIT antibodies to distinguish immune from non-immune forms. Review of patient history, especially recent heparin use. Monitoring for signs of new blood clots or bleeding complications. Additional laboratory assessments may include tests like the serotonin release assay, but these are more relevant for immune HIT.
Treatment Protocols: Discontinuing heparin therapy promptly upon suspicion or diagnosis. Switching to alternative anticoagulants if necessary, based on clinical needs. Monitoring platelet counts regularly to observe recovery. Providing supportive care to address any bleeding or clotting issues. Routine follow-up to ensure platelet counts return to normal and complications are avoided.
Clinical Advice & FAQs
Billing Guidance
Is D75.821 a billable ICD-10 code?
Yes, D75.821 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D75.821?
Clinical documentation must specify the nature of Non-immune heparin-induced thrombocytopenia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference